- Home
- MAMK vs RNXT Comparison
MAMK vs RNXT Comparison
Compare MAMK & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAMK
- RNXT
- Stock Information
- Founded
- MAMK 2007
- RNXT 2012
- Country
- MAMK China
- RNXT United States
- Employees
- MAMK N/A
- RNXT N/A
- Industry
- MAMK Apparel
- RNXT Biotechnology: Pharmaceutical Preparations
- Sector
- MAMK Consumer Discretionary
- RNXT Health Care
- Exchange
- MAMK Nasdaq
- RNXT Nasdaq
- Market Cap
- MAMK 43.2M
- RNXT 44.6M
- IPO Year
- MAMK 2025
- RNXT 2021
- Fundamental
- Price
- MAMK $2.47
- RNXT $1.14
- Analyst Decision
- MAMK
- RNXT Strong Buy
- Analyst Count
- MAMK 0
- RNXT 2
- Target Price
- MAMK N/A
- RNXT $7.25
- AVG Volume (30 Days)
- MAMK 615.1K
- RNXT 107.8K
- Earning Date
- MAMK 01-01-0001
- RNXT 08-14-2025
- Dividend Yield
- MAMK N/A
- RNXT N/A
- EPS Growth
- MAMK N/A
- RNXT N/A
- EPS
- MAMK 0.12
- RNXT N/A
- Revenue
- MAMK $21,434,100.00
- RNXT $240,000.00
- Revenue This Year
- MAMK N/A
- RNXT $3,104.65
- Revenue Next Year
- MAMK N/A
- RNXT $301.89
- P/E Ratio
- MAMK $20.43
- RNXT N/A
- Revenue Growth
- MAMK N/A
- RNXT N/A
- 52 Week Low
- MAMK $2.28
- RNXT $0.75
- 52 Week High
- MAMK $4.00
- RNXT $1.69
- Technical
- Relative Strength Index (RSI)
- MAMK N/A
- RNXT 33.69
- Support Level
- MAMK N/A
- RNXT $1.23
- Resistance Level
- MAMK N/A
- RNXT $1.28
- Average True Range (ATR)
- MAMK 0.00
- RNXT 0.06
- MACD
- MAMK 0.00
- RNXT -0.01
- Stochastic Oscillator
- MAMK 0.00
- RNXT 15.00
About MAMK MaxsMaking Inc. Class A Ordinary Shares
MaxsMaking Inc is a manufacturer of consumer goods with a focus on technology and innovation. It is serving small and medium-sized enterprises and individual e-commerce sellers with their needs for small batch products, It currently use cotton cloth, nylon cloth, polyester, recycled polyethylene terephthalate (rPET) and other materials to produce backpacks, shopping bags, aprons, tablecloths and other consumer goods. It serve enterprises, schools, government agencies, non-profit organizations, e-commerce sellers and various groups and organizations to meet their needs for small-batch products.
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.